Aileron Therapeutics Inc

1
NAS:ALRN (USA)  
$ 2.80 +0.025 (+0.9%) 01:30 PM EST
At Loss
P/B:
1.05
Market Cap:
$ 60.41M
Enterprise V:
$ 42.61M
Volume:
24.26K
Avg Vol (2M):
80.72K
Trade In:
Volume:
24.26K
At Loss
Avg Vol (2M):
80.72K

Business Description

Description
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.
Name Current Vs Industry Vs History
Cash-To-Debt 250.88
Equity-to-Asset 0.45
Interest Coverage No Debt
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 31.9
9-Day RSI 36.7
14-Day RSI 37.72
6-1 Month Momentum % -23.1
12-1 Month Momentum % 74.86

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.82
Quick Ratio 2.82
Cash Ratio 2.66

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -30.7
Shareholder Yield % 0.03
Name Current Vs Industry Vs History
ROE % -100.48
ROA % -36.25
ROIC % -52.77
ROC (Joel Greenblatt) % -64013.79
ROCE % -39.57

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 1.05
EV-to-EBIT -2.3
EV-to-EBITDA -2.31
EV-to-FCF -2.09
Earnings Yield (Greenblatt) % -43.48
FCF Yield % -33.8

Financials (Next Earnings Date:2024-08-09 Est.)

ALRN's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ALRN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Aileron Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -3.22
Beta 1.83
Volatility % 121.99
14-Day RSI 37.72
14-Day ATR ($) 0.264245
20-Day SMA ($) 2.945
12-1 Month Momentum % 74.86
52-Week Range ($) 1.01 - 7.42
Shares Outstanding (Mil) 21.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Aileron Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Aileron Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Aileron Therapeutics Inc Frequently Asked Questions

What is Aileron Therapeutics Inc(ALRN)'s stock price today?
The current price of ALRN is $2.80. The 52 week high of ALRN is $7.42 and 52 week low is $1.01.
When is next earnings date of Aileron Therapeutics Inc(ALRN)?
The next earnings date of Aileron Therapeutics Inc(ALRN) is 2024-08-09 Est..
Does Aileron Therapeutics Inc(ALRN) pay dividends? If so, how much?
Aileron Therapeutics Inc(ALRN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1